Israel Englander Repligen Corp Call Options Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $371,349 - $518,785
3,100 Added 6.14%
53,600 $7.98 Million
Q2 2024

Aug 14, 2024
BUY
$120.0 - $182.95 $6.06 Million - $9.24 Million
50,500 New
50,500 $6.37 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $2.05 Million - $2.67 Million
-14,800 Reduced 74.0%
5,200 $735,000
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $10.2 Million - $13.1 Million
-66,000 Reduced 76.74%
20,000 $3.37 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $14 Million - $19 Million
86,000 New
86,000 $14.6 Million

Others Institutions Holding RGEN

# of Institutions
486
Shares Held
54.3M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.87B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email